Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1833.HK Stock Summary
Top 10 Correlated ETFs
1833.HK
In the News
1833.HK Financial details
Company Rating
Neutral
Market Cap
14.18B
Income
-1.55B
Revenue
11.9B
Book val./share
12.55
Cash/share
7.76
Dividend
-
Dividend %
-
Employees
1.75K
Optionable
No
Shortable
Yes
Earnings
20 Mar 2024
P/E
-26.65
Forward P/E
236
PEG
-92.61
P/S
2.79
P/B
1.21
P/C
1.52
P/FCF
-20.35
Quick Ratio
2.9
Current Ratio
3.58
Debt / Equity
0.01
LT Debt / Equity
0
-
-
EPS (TTM)
-1.43
EPS next Y
0.05
EPS next Q
-
EPS this Y
-59.71%
EPS next Y
-103.31%
EPS next 5Y
-
EPS last 5Y
-10.41%
Revenue last 5Y
13.04%
Revenue Q/Q
-33.31%
EPS Q/Q
35.29%
-
-
-
-
SMA20
0.08%
SMA50
-24.13%
SMA100
-31.41%
Inst Own
0.02%
Inst Trans
0.03%
ROA
-4%
ROE
-4%
ROC
-0.09%
Gross Margin
27%
Oper. Margin
-19%
Profit Margin
-10%
Payout
-
Shs Outstand
1.11B
Shs Float
517.69M
-
-
-
-
Target Price
-
52W Range
10.6-22.85
52W High
-46.36%
52W Low
+18%
RSI
45.26
Rel Volume
0.68
Avg Volume
5.67M
Volume
3.84M
Perf Week
-3.12%
Perf Month
4.8%
Perf Quarter
-34.08%
Perf Half Y
-34.08%
-
-
-
-
Beta
0.51
-
-
Volatility
0.46%, 0.49%
Prev Close
-0.17%
Price
11.8
Change
-2.48%
1833.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.55 | 5.06 | 6.67 | 6.65 | 5.7 | |
Net income per share | -0.97 | -0.73 | -0.92 | -1.39 | -0.56 | |
Operating cash flow per share | -1.15 | -0.5 | -1.07 | -1.27 | -0.75 | |
Free cash flow per share | -1.36 | -0.64 | -1.14 | -1.35 | -0.78 | |
Cash per share | 7.65 | 5.56 | 9.68 | 4.72 | 4.67 | |
Book value per share | 10.85 | 9.64 | 15.38 | 12.77 | 12.45 | |
Tangible book value per share | 9.8 | 8.59 | 14.36 | 11.8 | 10.83 | |
Share holders equity per share | 10.85 | 9.64 | 15.38 | 12.77 | 12.45 | |
Interest debt per share | -0.03 | 0.11 | 0.12 | 0.19 | 0.17 | |
Market cap | 22.76B | 50.81B | 81.07B | 25.52B | 20.33B | |
Enterprise value | 21.84B | 45.94B | 73.26B | 22.65B | 16.81B | |
P/E ratio | -24.97 | -69.24 | -85.48 | -16.59 | -33.46 | |
Price to sales ratio | 6.82 | 10.03 | 11.81 | 3.48 | 3.3 | |
POCF ratio | -20.98 | -100.78 | -73.55 | -18.19 | -25.08 | |
PFCF ratio | -17.74 | -79.74 | -68.97 | -17.1 | -24.06 | |
P/B Ratio | 2.23 | 5.27 | 5.12 | 1.81 | 1.51 | |
PTB ratio | 2.23 | 5.27 | 5.12 | 1.81 | 1.51 | |
EV to sales | 6.54 | 9.07 | 10.67 | 3.09 | 2.73 | |
Enterprise value over EBITDA | -24.39 | -45.7 | -121.06 | -12.85 | -16.47 | |
EV to operating cash flow | -20.12 | -91.12 | -66.47 | -16.15 | -20.73 | |
EV to free cash flow | -17.02 | -72.1 | -62.33 | -15.18 | -19.89 | |
Earnings yield | -0.04 | -0.01 | -0.01 | -0.06 | -0.03 | |
Free cash flow yield | -0.06 | -0.01 | -0.01 | -0.06 | -0.04 | |
Debt to equity | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to assets | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | 1.03 | 4.84 | 12.9 | 1.62 | 3.45 | |
Current ratio | 3.84 | 3.18 | 5.72 | 3.47 | 3.58 | |
Interest coverage | 37.77 | -80.96 | -113.74 | -169.79 | -98.42 | |
Income quality | 1.19 | 0.69 | 1.16 | 0.91 | 1.33 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0.02 | |
Payout ratio | 0 | 0 | 0 | -0.2 | -0.52 | |
Sales general and administrative to revenue | 0.3 | 0.21 | 0.15 | 0.25 | 0.28 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.09 | 0.09 | 0.06 | 0.06 | 0.1 | |
Capex to operating cash flow | 0.18 | 0.26 | 0.07 | 0.06 | 0.04 | |
Capex to revenue | -0.06 | -0.03 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -4.44 | -1.05 | -0.49 | -0.49 | -0.21 | |
Stock based compensation to revenue | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 | |
Graham number | 15.39 | 12.61 | 17.86 | 20.02 | 12.55 | |
ROIC | -0.11 | -0.11 | -0.04 | -0.13 | -0.08 | |
Return on tangible assets | -0.08 | -0.06 | -0.05 | -0.09 | -0.04 | |
Graham Net | 6.12 | 3.49 | 7.98 | 2.57 | 2.53 | |
Working capital | 5.99B | 5.81B | 12.59B | 9.08B | 8.98B | |
Tangible asset value | 9.21B | 8.6B | 14.78B | 13.01B | 11.71B | |
Net current asset value | 5.99B | 5.77B | 12.55B | 8.96B | 8.78B | |
Invested capital | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Average receivables | 686.58M | 825.62M | 975.37M | 1.4B | 1.65B | |
Average payables | 476.18M | 408.39M | 452.71M | 822.6M | 943.12M | |
Average inventory | 25.23M | 58.04M | 117.62M | 279.27M | 322.07M | |
Days sales outstanding | 94.12 | 56.96 | 61.68 | 81.41 | 98.45 | |
Days payables outstanding | 63.3 | 37.12 | 37.17 | 73.67 | 61.2 | |
Days of inventory on hand | 6.22 | 7.01 | 11.71 | 25.82 | 20.07 | |
Receivables turnover | 3.88 | 6.41 | 5.92 | 4.48 | 3.71 | |
Payables turnover | 5.77 | 9.83 | 9.82 | 4.95 | 5.96 | |
Inventory turnover | 58.71 | 52.08 | 31.17 | 14.14 | 18.19 | |
ROE | -0.09 | -0.08 | -0.06 | -0.11 | -0.05 | |
Capex per share | -0.21 | -0.13 | -0.07 | -0.08 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.47 | 3.18 | 2.63 | 3.09 | 2.09 | |
Net income per share | -0.8 | -0.6 | -0.43 | -0.17 | -0.23 | |
Operating cash flow per share | -0.29 | -0.98 | -0.08 | -0.67 | -0.06 | |
Free cash flow per share | -0.32 | -1.03 | -0.09 | -0.69 | -0.08 | |
Cash per share | 3.48 | 4.71 | 4.89 | 4.68 | 7.76 | |
Book value per share | 13.65 | 12.74 | 12.59 | 12.48 | 12.55 | |
Tangible book value per share | 12.71 | 11.77 | 11.6 | 10.85 | 10.92 | |
Share holders equity per share | 13.65 | 12.74 | 12.59 | 12.48 | 12.55 | |
Interest debt per share | 0.17 | 0.18 | 0.21 | 0.16 | 0.07 | |
Market cap | 88.52B | 25.57B | 21.34B | 20.29B | 18.62B | |
Enterprise value | 84.93B | 22.71B | 18.37B | 16.76B | 14.15B | |
P/E ratio | -25.16 | -9.71 | -11.54 | -27.68 | -19.02 | |
Price to sales ratio | 23.18 | 7.27 | 7.54 | 6.09 | 8.38 | |
POCF ratio | -278.78 | -23.56 | -241.1 | -28.09 | -276.75 | |
PFCF ratio | -250.2 | -22.46 | -211.5 | -27.26 | -220.56 | |
P/B Ratio | 5.9 | 1.82 | 1.58 | 1.51 | 1.39 | |
PTB ratio | 5.9 | 1.82 | 1.58 | 1.51 | 1.39 | |
EV to sales | 22.24 | 6.46 | 6.49 | 5.03 | 6.37 | |
Enterprise value over EBITDA | -94.88 | -26.17 | -31.26 | -35.66 | -33.85 | |
EV to operating cash flow | -267.48 | -20.92 | -207.56 | -23.21 | -210.44 | |
EV to free cash flow | -240.05 | -19.95 | -182.09 | -22.53 | -167.71 | |
Earnings yield | -0.01 | -0.03 | -0.02 | -0.01 | -0.01 | |
Free cash flow yield | 0 | -0.04 | 0 | -0.04 | 0 | |
Debt to equity | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Net debt to EBITDA | 4.01 | 3.3 | 5.05 | 7.5 | 10.66 | |
Current ratio | 3.32 | 3.47 | 3.72 | 3.58 | 4.26 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0.36 | 1.65 | 0.19 | 3.94 | 0.27 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.24 | 0.27 | 0.32 | 0.26 | 0.34 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.06 | 0.06 | 0.06 | 0.1 | 0.1 | |
Capex to operating cash flow | 0.11 | 0.05 | 0.14 | 0.03 | 0.25 | |
Capex to revenue | -0.01 | -0.02 | 0 | -0.01 | -0.01 | |
Capex to depreciation | -0.41 | -0.58 | -0.14 | -0.3 | -0.24 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0 | |
Graham number | 15.68 | 13.07 | 11.03 | 6.91 | 8.06 | |
ROIC | -0.06 | -0.06 | -0.05 | -0.04 | -0.03 | |
Return on tangible assets | -0.05 | -0.04 | -0.03 | -0.01 | -0.02 | |
Graham Net | 1.11 | 2.56 | 2.67 | 2.53 | 5.58 | |
Working capital | 7.96B | 9.08B | 9.06B | 8.98B | 10.21B | |
Tangible asset value | 13.97B | 13.01B | 12.48B | 11.71B | 11.61B | |
Net current asset value | 7.86B | 8.96B | 8.92B | 8.78B | 10.03B | |
Invested capital | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 27.72 | 41.87 | 43.58 | 44.88 | 49.43 | |
Days payables outstanding | 26.33 | 36.07 | 35.41 | 27.9 | 47.29 | |
Days of inventory on hand | 3.61 | 12.64 | 4.48 | 9.15 | 9.71 | |
Receivables turnover | 3.25 | 2.15 | 2.07 | 2.01 | 1.82 | |
Payables turnover | 3.42 | 2.5 | 2.54 | 3.23 | 1.9 | |
Inventory turnover | 24.92 | 7.12 | 20.07 | 9.84 | 9.27 | |
ROE | -0.06 | -0.05 | -0.03 | -0.01 | -0.02 | |
Capex per share | -0.03 | -0.05 | -0.01 | -0.02 | -0.02 |
1833.HK Frequently Asked Questions
What is Ping An Healthcare and Technology Company Limited stock symbol ?
Ping An Healthcare and Technology Company Limited is a CN stock and trading under the symbol 1833.HK
What is Ping An Healthcare and Technology Company Limited stock quote today ?
Ping An Healthcare and Technology Company Limited stock price is $11.8 today.
Is Ping An Healthcare and Technology Company Limited stock public?
Yes, Ping An Healthcare and Technology Company Limited is a publicly traded company.